Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Supplement Firms Should Work Toward Sharing GMP Audits – FDA's Williams

This article was originally published in The Tan Sheet

Executive Summary

FDA dietary supplement program official Brad Williams personally endorses the sharing of supplier audit reports to improve firms' compliance with good manufacturing practices.
Advertisement

Related Content

Convoluted Herbal Requirements Foretell FSMA Complexities
Convoluted Herbal Requirements Foretell FSMA Complexities
GMP Qualification And Testing Provisions Still Trip Supplement Firms
GMP Inspectors Find "Dismal" Compliance, Smell "Blood In The Water"
In Brief
Interview: CRN Vet Shao Brings Broad Industry Perspective To Herbalife
FDA Sending Steady Stream Of Supplement GMP Warnings In 2011
One-Third Of Supplement GMP Inspections Reveal "Serious Problems" - FDA
As Supplement GMP Implementation Hits Zero Hour, Small Firms Still Struggle
As Supplement GMP Implementation Hits Zero Hour, Small Firms Still Struggle

Topics

Advertisement
UsernamePublicRestriction

Register

PS104939

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel